Bio-Path Holdings, Inc. (BPTH)

Bio-Path Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	4.34	4.24	4.74	4.53	4.33	4.11
Research & Development	9.91	11.61	9.17	5.91	6.58	4.59
Operating Expenses	14.25	15.84	13.9	10.44	10.91	8.69
Operating Income	-14.25	-15.84	-13.9	-10.44	-10.91	-8.69
Other Expense / Income	-0.28	0.24	-0.03	-0	-0.03	-0.09
Pretax Income	-13.96	-16.08	-13.87	-10.44	-10.88	-8.6
Net Income	-13.96	-16.08	-13.87	-10.44	-10.88	-8.6
Shares Outstanding (Basic)	1	0	0	0	0	0
Shares Outstanding (Diluted)	1	0	0	0	0	0
Shares Change	62.56%	31.32%	8.25%	74.81%	44.79%	345.06%
EPS (Basic)	-26.11	-33.63	-38.12	-31.00	-56.60	-64.80
EPS (Diluted)	-26.11	-33.63	-38.12	-31.00	-56.60	-64.80
Free Cash Flow	-8.92	-11.54	-15.12	-9.99	-10.96	-8.36
Free Cash Flow Per Share	-13.79	-24.13	-41.55	-29.70	-56.98	-62.94
EBITDA	-13.78	-15.9	-13.69	-10.28	-10.73	-8.37
Depreciation & Amortization	0.18	0.18	0.18	0.16	0.15	0.23
EBIT	-13.96	-16.08	-13.87	-10.44	-10.88	-8.6

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).